Skip to main content

Table 6 Patient-related outcomes pre- and post-intervention

From: Feasibility and cost description of highly intensive rehabilitation involving new technologies in patients with post-acute stroke—a trial of the Swiss RehabTech Initiative

  Pre-intervention Post-intervention Median change [95% CI] p (α = 0.05) r [95% CI]
Lower extremity, gait, and balance
 10MWT (in seconds) comfortable (N = 12) 28.6 [22.9] 19.0 [19.6] − 1.75 [− 8.4 to − 0.6] 0.014 0.738 [0.38–0.89]
 10MWT (in seconds) maximum (N = 12) 21.6 [23.4] 15.1 [19.3] − 1.25 [− 9.5 to − 0.9] 0.016 0.679 [0.29–0.89]
 CSMA-WI, walking capacity 16 [8.3] 19 (7.8) 2 [0.0–3.5] NS
 BBS, balance abilities 32 [24] 39 [18.8] 5.5 [2.0–9.0] 0.001 0.88 [0.88–0.89]
 FAC, mobility status 2 [2] 3.5 (3) 0.5 [0.0–1.0] 0.015 0.703 [0.46–0.86]
Upper extremity
 FMA-UE, upper extremity motor function 16 [12.5] 27.5 [23.8] 8 [3.0–12.0] 0.002 0.87 [0.84–0.91]
 BBT, gross manual dexterity (affected side) 0 [19.8] 1 [30.8] 1 [0.0–8.0] 0.014 0.74 [0.53–0.86]
Generic outcome measures
 SIS, stroke impact (64–320) 219 [39.8] 238 [38] 13 [0.0–39.0] 0.003 0.78 [0.54–0.88]
 SIS, stroke recovery (0–100%) 50 [35] 65.5 [17.5] 7.5 [− 5.0 to 30.0] NS
 FIM, generic functional performance 102 [47.5] 104.5 [32.5] 5.0 [1.0–13.0] 0.002 0.86 [0.78–0.89]
 EQ-5D Index 0.7 [0.16] 0.8 [0.14] 0.09 [0.0–0.1] NS
  1. Sampling units: N = 14; CI confidence interval, P p-value provided by Wilcoxon signed-rank test, NS non-significant, r effect size r, calculated as z statistic extracted from a paired-sample Wilcoxon signed-rank test, divided by square root of the sample size, 10MWT 10 Meter Walking Test, CSMA-WI Chedoke-McMaster Stroke Assessment – Walking Index, BBS Berg Balance Scale, FAC Functional Ambulation Category, FMA-UE Fugl-Meyer Assessment -Upper Extremity, BBT Box&Block Test, SIS Stroke Impact Scale, FIM Functional Independence Measure